Anavex Life Sciences: Pay

Anavex Life Sciences paid its 2 named executives $3.2M in total in FY2024 (Sep). CEO Christopher Missling was paid $2.8M of that.

Pay$100 in the stock at the end of FY20 → $125

CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Christopher MisslingPresident, Chief Executive Officer and Director


FY2024 (Sep)
FY2023 (Sep)
FY2022 (Sep)							Not disclosed
FY2021 (Sep)							Not disclosed

4 years

Sandra Boenisch


FY2024 (Sep)
FY2023 (Sep)

2 years

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.